155 related articles for article (PubMed ID: 6768113)
1. Anti-oestrogen action in experimental breast cancer.
Jordan VC; Naylor KE; Dix CJ; Prestwich G
Recent Results Cancer Res; 1980; 71():30-44. PubMed ID: 6768113
[No Abstract] [Full Text] [Related]
2. Comparative antioestrogen action in experimental breast cancer.
Jordan VC
Adv Exp Med Biol; 1981; 138():165-78. PubMed ID: 6805259
[No Abstract] [Full Text] [Related]
3. The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours.
Daniel CP; Gaskell SJ; Nicholson RI
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):137-43. PubMed ID: 6420159
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system.
Rorke EA; Katzenellenbogen BS
Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294
[No Abstract] [Full Text] [Related]
5. Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model.
Jordan VC; Allen KE
Eur J Cancer (1965); 1980 Feb; 16(2):239-51. PubMed ID: 6768559
[No Abstract] [Full Text] [Related]
6. Tamoxifen as an anti-tumour agent: effect on oestrogen binding.
Jordan VC; Dowse LJ
J Endocrinol; 1976 Feb; 68(02):297-303. PubMed ID: 176295
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the efficacy for antitumor activity of the non-steroidal antiestrogens analog II and tamoxifen in 7,12-dimethylbenz[a] anthracene-induced rat mammary tumors.
Pento JT; Magarian RA; King MM
Cancer Lett; 1982; 15(3):261-9. PubMed ID: 6811128
[No Abstract] [Full Text] [Related]
8. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
Manni A; Trujillo JE; Pearson OH
Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
[TBL] [Abstract][Full Text] [Related]
9. The effect of synthetic anti-oestrogens on the growth and biochemistry of rat mammary tumours.
Nicholson RI; Golder MP
Eur J Cancer (1965); 1975 Aug; 11(8):571-9. PubMed ID: 816655
[No Abstract] [Full Text] [Related]
10. Pharmacology of tamoxifen in laboratory animals.
Jordan VC; Allen KE; Dix CJ
Cancer Treat Rep; 1980; 64(6-7):745-59. PubMed ID: 6775807
[TBL] [Abstract][Full Text] [Related]
11. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.
Jordan VC
Breast Cancer Res Treat; 1983; 3 Suppl():S73-86. PubMed ID: 6423014
[TBL] [Abstract][Full Text] [Related]
12. Activity of the antioestrogen trioxifene against N-Nitrosomethylurea-induced rat mammary carcinomas.
Rose DP; Fischer AH; Jordan VC
Eur J Cancer Clin Oncol; 1981 Aug; 17(8):893-8. PubMed ID: 7198978
[No Abstract] [Full Text] [Related]
13. Oestrogen receptor activity and endocrine status in DMBA-induced rat mammary tumours.
Hawkins RA; Hill A; Freedman B; Killen E; Buchan P; Miller WR; Forrest AP
Eur J Cancer (1965); 1977 Mar; 13(3):223-8. PubMed ID: 405220
[No Abstract] [Full Text] [Related]
14. A new triphenylethylene derivative, TAT-59; hormone receptors; insulin-like growth factor 1; and growth suppression of hormone-dependent MCF-7 tumors in athymic mice.
Iino Y; Takai Y; Ando T; Ohwada S; Yokoe T; Sugamata N; Takei H; Horiguchi J; Iijima K; Morishita Y
Cancer Chemother Pharmacol; 1994; 34(5):372-6. PubMed ID: 8070003
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and scintigraphy of 11C-toremifene in rats bearing DMBA-induced mammary carcinoma.
Kangas L; Haaparanta M; Paul R; Roeda D; Sipilä H
Pharmacol Toxicol; 1989 Apr; 64(4):373-7. PubMed ID: 2526330
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution of 123I-labeled 4-hydroxytamoxifen derivatives in rats with dimethylbenzanthracene-induced mammary carcinomas.
Kruijer PS; Klok RP; van den Koedijk CD; Blankenstein MA; Voskuil JH; Verzeijlbergen JF; Ensing GJ; Herscheid JD
Nucl Med Biol; 1997 Nov; 24(8):719-22. PubMed ID: 9428596
[TBL] [Abstract][Full Text] [Related]
17. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.
Janssens JP; Billiet G; Bonte J; De Loecker W
Anticancer Res; 1983; 3(6):385-91. PubMed ID: 6230984
[TBL] [Abstract][Full Text] [Related]
18. Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
Tominaga T; Yoshida Y; Shimozuma K; Hayashi K; Kosaki G
Eur J Cancer; 1990; 26(5):600-3. PubMed ID: 2144748
[TBL] [Abstract][Full Text] [Related]
19. Laboratory models of breast cancer to aid the elucidation of antiestrogen action.
Jordan VC
J Lab Clin Med; 1987 Mar; 109(3):267-77. PubMed ID: 3102656
[TBL] [Abstract][Full Text] [Related]
20. The effects of intermittent progesterone upon tamoxifen inhibition of tumor growth in the 7,12-dimethylbenzanthracene rat mammary tumor model.
Gibson DF; Johnson DA; Langan-Fahey SM; Lababidi MK; Wolberg WH; Jordan VC
Breast Cancer Res Treat; 1993 Sep; 27(3):283-7. PubMed ID: 8312587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
